This article is available online at http://www.jlr.org phase of NAFLD ( 2 ). Furthermore, results of recent studies suggest that steatosis may play a critical role not only in the onset of NAFLD but also in its progression to later stages of the disease (e.g., fi brosis and cirrhosis ( 3 )). Therefore, therapies protecting against the onset of NAFLD may also be benefi cial for the later stages of the disease.Results of several epidemiologic and clinical studies indicate that besides a general over-nutrition dietary intake of carbohydrates and fructose consumption in particular may play a critical role in the development of NAFLD in humans ( 4 ). The hypothesis that a diet rich in mono-and disaccharides, such as fructose and sucrose, might play a critical role in the pathogenesis of NAFLD is also supported by a number of studies performed in animals. In these studies, it was shown that an increased consumption of fructose (e.g., up to 60% of daily calories derived from fructose) resulted in an increased lipid accumulation in the liver, which was accompanied by insulin resistance, elevated plasma triglyceride levels, and oxidative stress ( 5-9 ). Recently, our group was able to show that hepatic steatosis resulting from chronic intake of fructose is associated with a loss of the tight junction protein occludin in the duodenum, an increased translocation of bacterial endotoxins from the intestine, and an induction of tumor necrosis factor (TNF) ␣ in the liver of mice ( 7, 10, 11 ). However, while plasma levels of TNF ␣ and retinol binding protein 4 were both increased under this feeding regimen, suggesting that fructose-fed mice were insulin-resistant, glucose levels in blood of food-deprived, fructose-fed mice did not differ from those of water-fed controls ( 7, 10 ). In these studies, the concomitant treatment with antibiotics Abstract Fructose intake is being discussed as a key dietary factor in the development of nonalcoholic fatty liver disease (NAFLD). Bile acids have been shown to modulate energy metabolism. We tested the effects of bile acids on fructoseinduced hepatic steatosis. In C57BL/6J mice treated with a combination of chenodeoxycholic acid and cholic acid (100 mg/kg body weight each) while drinking water or a 30% fructose solution for eight weeks and appropriate controls, markers of hepatic steatosis, portal endotoxin levels, and markers of hepatic lipogenesis were determined. In mice concomitantly treated with bile acids, the onset of fructoseinduced hepatic steatosis was markedly attenuated compared to mice only fed fructose. The protective effects of the bile acid treatment were associated with a downregulation of tumor necrosis factor (TNF) ␣ , sterol regulatory element-binding protein (SREBP)1, FAS mRNA expression, and lipid peroxidation in the liver, whereas hepatic farnesoid X receptor (FXR) or short heterodimer partner (SHP) protein concentration did not differ between groups fed fructose. Rather, bile acid treatment normalized occludin protein concentration in the duodenum, portal endotoxin...